Tower Research Capital (TRC)’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-15,504
| Closed | -$8K | – | 5100 |
|
2016
Q3 | $8K | Sell |
15,504
-5,891
| -28% | -$3.04K | ﹤0.01% | 2296 |
|
2016
Q2 | $12K | Buy |
21,395
+20,939
| +4,592% | +$11.7K | ﹤0.01% | 2705 |
|
2016
Q1 | $1K | Sell |
456
-2,517
| -85% | -$5.52K | ﹤0.01% | 4001 |
|
2015
Q4 | $10K | Buy |
2,973
+988
| +50% | +$3.32K | ﹤0.01% | 2223 |
|
2015
Q3 | $13K | Sell |
1,985
-1,513
| -43% | -$9.91K | ﹤0.01% | 2135 |
|
2015
Q2 | $35K | Sell |
3,498
-7,595
| -68% | -$76K | ﹤0.01% | 1648 |
|
2015
Q1 | $82K | Buy |
11,093
+10,865
| +4,765% | +$80.3K | 0.01% | 1060 |
|
2014
Q4 | $1K | Sell |
228
-5,408
| -96% | -$23.7K | ﹤0.01% | 3914 |
|
2014
Q3 | $28K | Buy |
5,636
+3,359
| +148% | +$16.7K | ﹤0.01% | 2054 |
|
2014
Q2 | $15K | Sell |
2,277
-4,016
| -64% | -$26.5K | ﹤0.01% | 2079 |
|
2014
Q1 | $46K | Buy |
+6,293
| New | +$46K | 0.01% | 1162 |
|